Cost of quality reporting: Some Australian evidence |
| |
| Institution: | 1. Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan;2. Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan;3. Natioanl Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan;4. Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;5. Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan;6. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;7. Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;8. Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;9. Department of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan;10. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;11. Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan;12. Division of Urology, Chi Mei Medical Center, Tainan, Taiwan;13. Department of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan |
| |
| Abstract: | The study explored the quality management practices, specifically addressing cost of quality reporting, of Australian manufacturers certified to AS/NZS ISO 9000. The findings suggest that firms have responded to the demands of the new manufacturing environment and have implemented quality management initiatives in an effort to gain a competitive advantage in the marketplace. The minority of respondents prepared cost of quality reports. For those firms reporting quality costs, the motivation was to identify high-cost problem areas. Firms not reporting quality costs cited lack of management support and the belief that quality was part of the firm's culture. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
